¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Epilepsy, Benign Neonatal"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® epilepsy ÇÑ±Û °£Áú
¼³¸í   
  µ¹¹ßÀûÀ̰í ÀϰúÀûÀΠ¹ßÀÛÀ» Æ¯Â¡À¸·Î Çϴ ¸¸¼º ÁßÃ߽Űæ°è ÁúȯÀÇ ÃÑĪÀ̸砰øÅëÀûÀ¸·Î ¿îµ¿, Áö°¢, ÀÚÀ²½Å°æ°è È¤Àº Á¤½Å Áõ»óÀ» ³ªÅ¸³»°í °ÅÀÇ ¸ðµç °æ¿ì¿¡ ºñÁ¤»óÀûÀΠ³úÆÄ ¾ç»óÀ» ³ªÅ¸³½´Ù.
  
  ³úÁ¶Á÷ÀÇ º´ÅÍ ¶Ç´Â ±â´ÉÀûÀΠÀå¾Ö·Î ÀÎÇÏ¿© ¹ßÀÛÀûÀ¸·Î ½Å°æ±â´ÉÀå¾Ö¸¦ ÀÏÀ¸ÄÑ ¿©·¯ °¡Áö ½Å°æÁõ»ó, Áï µ¹¹ßÀûÀΠÀǽĻó½Ç, °æ·Ã, Á¤½Å ¶Ç´Â °¨°¢Àå¾Ö¸¦ ÀÏÀ¸Å°´Â Áúȯ, Àü°£ ¶Ç´Â Áö¶öº´À̶ó°íµµ ÇÑ´Ù. ÀüÀα¸ÀÇ ¾à 0.5%~1%¿¡¼­ º¼ ¼ö Àִ ÈçÇÑ Áúº´À¸·Î¼­, Á¾Àü¿£ À¯Àüº´À̳ª ºÒÄ¡ÀÇ º´À¸·Î ´ÜÁ¤ÇÏ¿© Ä¡·á¸¦ ±âÇÇÇϴ °æÇâÀÌ ÀÖ¾ú´Ù. ±×·¯³ª °£ÁúÀÇ ¿øÀΰú Ä¡·á¸é¿¡¼­ ±Ù·¡¿¡ ¸¹Àº ¹ßÀüÀÌ ÀÖ¾î ÇöÀç´Â ¾à¹°Ä¡·á¿Í ³ú¼ö¼ú·Î½á °£Áú È¯ÀÚÀÇ ¾à 80%¸¦ Ä¡À¯ÇÒ ¼ö ÀÖ´Ù.
  
  °£ÁúÀº ³úÀÇ ÀÌ»óÀ̳ª, ÀÌ¿¡ µû¸¥ Æ¯Â¡ÀûÀΠ½ÅüÁõ»óµµ °°ÀÌ ³ªÅ¸³­´Ù. ´Ù¾çÇÑ ÇüŰ¡ ÀÖÀ¸¸ç, ³úÆÄ°Ë»ç»ó Àü¹ÝÀûÀΠ³úÀüüÀÇ ÀÌ»óÀÌ ³ªÅ¸³ª¸é Àü½Å¹ßÀÛ(generalized seizure(=epilepsy))À̶ó°í Çϸç, ÀϺÎÀÇ ³ú¿¡¼­ ÀÌ»óÀÌ ³ªÅ¸³ª¸é ºÎºÐ¹ßÀÛ(partial seizure)À̶ó°í ÇÑ´Ù. ¶ÇÇÑ Àü½Å¹ßÀÛ¿¡´Â Å« ÆÈ´Ù¸®ÀÇ ¿îµ¿°ú ÀǽļҽÇ, ÀÚÀ²½Å°æÀÌ»ó µîÀ» È£¼ÒÇϴ °¡Àå ½ÉÇÑ ÇüÅÂÀÇ ´ë¹ßÀÛ(grand mal seizure)¿Í, Àá±ñÀÇ ÀǽļҽǸ¸À» È£¼ÒÇϴ ¼Ò¹ßÀÛ(petit mal seizure)°¡ ÀÖ´Ù. ±×¸®°í ºÎºÐ¹ßÀÛ¿¡´Â ¿îµ¿ºÎÀ§¿¡¸¸ ÀÌ»óÀÌ ³ªÅ¸³ª´Â ¿îµ¿¹ßÀÛ(motor seizure), °¨°¢ºÎÀ§¿¡¸¸ ÀÌ»óÀÌ ³ªÅ¸³ª´Â °¨°¢¹ßÀÛ(sensory seizure), ±×¸®°í °üÀÚ¿±ÀÇ ÀÌ»ó³úÆÄ¼Ò°ßÀ» ³ªÅ¸³»´Â °üÀÚ¿± ¹ßÀÛ(temporal lobe seizure) µîÀÌ ÀÖ´Ù. 3¼¼ ¼Ò¾Æ¿¡ ÀϾ°í, ´Ü¼øÈ÷ ÀǽļҽÇ(5~10Ãʰ£)À» ³ªÅ¸³½´Ù.
¿µ¹® neonatal intensive care center ÇÑ±Û ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
¼³¸í   
  ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇϴ ±â°ü.
¿µ¹® benign ÇÑ±Û ¾ç¼º
¼³¸í   
  Ä¡À¯°¡ Àß µÇ´Â, Á¾¾çÀÇ °æ¿ì¿¡¼­´Â ´Ù¸¥ Á¶Á÷À¸·Î ÆÛÁöÁö ¾Ê°í ±×ºÎºÐ¿¡¼­ ¸Ó¹°·¯ Àִ Á¾¾çÀ» ¸»ÇÑ´Ù.
¿µ¹® benign tumor ÇÑ±Û ¾ç¼ºÁ¾¾ç
¼³¸í   
  ¹ßÀ°¼Óµµ°¡ ¿Ï¸¸ÇÏ¿© ¼ºÀå¿¡ ÇѰ谡 ÀÖ°í, ÁÖÀ§¿ÍÀÇ °æ°è°¡ ¸íÈ®Çϸç, ´Ù¸¥ Á¶Á÷À¸·Î ÆÛÁöÁö ¾ÊÀ¸¸ç, Ä§À±À̳ª ÀüÀ̸¦ ÀÏÀ¸Å°Áö ¾Æ´ÏÇϴ Á¾¾ç. ¼¶À¯Á¾À̳ª Áö¹æÁ¾ µûÀ§°¡ ÀüÇüÀûÀΠ¿¹ÀÌ´Ù. ¾ç¼ºÁ¾¾çÀº Á¾¾çÀÌ Á¸ÀçÇÑ´Ù°í Çصµ 1Â÷ÀûÀ¸·Î ¼÷ÁÖÀÇ »ý¸íÀ» À§ÇùÇϴ ÀÏÀº ¾ø´Ù. ¾ç¼ºÁ¾¾çÀÇ ¹ßÀ°Çü½ÄÀº ÁÖÀ§ÀÇ Á¶Á÷°£¿¡ ¿Õ·¡Çϴ ÀÏÀÌ ¾øÀÌ ÁÖÀ§ÀÇ Á¶Á÷À» ¹Ð¾î³»¸ç Áõ½ÄÇÑ´Ù. ¹ßÀ°¼Óµµ´Â ¿Ï¸¸Çϸç ÀüÀÌÇϰųª ÀýÁ¦ ÈÄ Àç¹ßÇϴ ÀÏÀÌ ±ØÈ÷ µå¹°´Ù. Á¾¾ç¼ººÐÀº º¯ÀÌüÀ̱ä ÇÏÁö¸¸ ¼º¼÷ÇÑ Á¤»ó¼¼Æ÷¿Í °ÅÀÇ ´Ù¸¥ °ÍÀÌ ¾ø´Ù. Àü½Å¿¡ ´ëÇÑ ¿µÇâÀº ¾Ç¼ºÁ¾¾çÀÇ °æ¿ì ¾î´À Á¤µµ ¹ßÀ°ÇßÀ» ¶§ Àü½ÅÀÇ ¿µ¾ç»óŰ¡ ¼Õ»óµÇ¾î Ä«Äʽþư¡ µÇÁö¸¸ ¾ç¼ºÁ¾¾çÀÇ °æ¿ì ÀÌ·± ÀÏÀº °ÅÀÇ ¾ø´Ù. ¾ç¼ºÁ¾¾ç°ú ¾Ç¼ºÁ¾¾çÀÇ ¼º»óÀÇ Â÷ÀÌ¿¡ ¾ö¹ÐÇÑ °æ°è´Â ¾ø°í, °æ°è°æº¯À¸·Î º¸À̴ Á¾¾çµµ ÀÖ´Ù.
¿µ¹® Benign Prostatic Hyperplasia(BPH) ÇÑ±Û Àü¸³»ùºñ´ë
¼³¸í   
  50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇϴ º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû È¤Àº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇؾߠÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • benign
    ¾ç¼º-
  • benign cyst
    1. ¾ç¼º³¶, ¾ç¼º¹°È¤ 2. ¾ç¼º³¶Á¾
  • benign juvenile melanoma
    ¾ç¼º¼Ò¾ÆÈæ»öÁ¾
  • benign lichenoid keratosis
    ¾ç¼ºÅ¼±°¢È­Áõ
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • benign masseteric hypertrophy
    ¾ç¼º±ú¹°±Ùºñ´ë, ¾ç¼º±³±Ùºñ´ë
  • benign migratory glossitis
    ¾ç¼ºÀÌÁÖÇô¿°, ¾ç¼ºÀÌÁÖ¼³¿°
  • benign neoplasm
    ¾ç¼ºÁ¾¾ç
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³»ùºñ´ë, ¾ç¼ºÀü¸³¼±ºñ´ë
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¾ç¼º»óÇdz»ÀÌ»ó°¢È­Áõ
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • neonatal
    ½Å»ý¾Æ-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benign cyst
    1.¾ç¼º³¶, ¾ç¼º¹°È¤, 2.¾ç¼º³¶Á¾
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • benign cystic teratoma
    ¾ç¼º³¶±âÇüÁ¾
  • epilepsy
    °£Áú
  • focal epilepsy
    ¿îµ¿ÁßÃß¼Õ»ó°£Áú, ÃÊÁ¡°£Áú
  • generalized epilepsy
    Àü½Å°£Áú
  • localized epilepsy
    ±¹¼Ò°£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ
  • temporal lobe epilepsy
    °üÀÚ¿±°£Áú, ÃøµÎ¿±°£Áú
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • benign
    ¾ç¼º-
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • benign cystic teratoma
    ¾ç¼º³¶±âÇüÁ¾
  • benign juvenile melanoma
    ¾ç¼º¿¬¼ÒÈæ»öÁ¾
  • benign lichenoid keratosis
    ¾ç¼ºÅ¼±¾ç°¢È­Áõ
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • benign masseteric hypertrophy
    ¾ç¼º±ú¹°±Ùºñ´ë
  • benign migratory glossitis
    ¾ç¼ºÀÌÁÖÇô¿°
  • benign papular acantholytic dermatosis
    ¾ç¼º±¸Áø°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³»ùºñ´ë
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¾ç¼º»óÇdz»ÀÌ»ó°¢È­Áõ
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • grand mal epilepsy See epilepsy
    ´ë¹ßÀÛ°£Áú(ÓÞÛ¡íÂÊÖòð)
  • Hailey-Hailey disease = familial benign chronic pemphigus
    ÇìÀϸ®-ÇìÀϸ®º´
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¼º ¾ç¼º »óÇdz» ÀÌ»ó°¢È­Áõ
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • Jacksonian epilepsy
    Àè½¼°£Áú.
  • abortive epilepsy
    ºÎÀü°£Áú.
  • affect epilepsy
    Á¤µ¿¼º °£Áú(ï×ÔÑàõÊÖòð).
  • arithmetical epilepsy
    »ê¼ú¼º °£Áú
  • genuine epilepsy
    Áø¼º°£Áú.
  • grand mal epilepsy
    ´ë¹ßÀÛ°£Áú.
  • gustatory epilepsy
    ¹Ì°¢¼º °£Áú.
  • hereditary epilepsy
    À¯Àü¼º °£Áú(¡­ÊÖòð).
  • hiernosus =epilepsy
    °£Áú(ÊÖòð).
  • hysterical epilepsy
    È÷½ºÅ׸®¼º °£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ°£Áú(¡­ÊÖòð).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benign partial epilepsy of childhood
    ¼Ò¾Æ±â ¾ç¼ººÎºÐ°£Áú
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú(~ÊÖòð).
  • grand mal epilepsy See epilepsy
    ´ë¹ßÀÛ°£Áú(ÓÞÛ¡íÂÊÖòð)
  • benign
    ¾ç¼º(åÐàõ).
  • benign cephalic histiocytosis
    ¾ç¼º µÎºÎÁ¶Á÷±¸Áõ
  • benign cystic teratoma
    ¾ç¼º±âÇüÁ¾
  • benign dermatopathic lymphadenopathy
    ¾ç¼º ÇǺκ´¼º¸²ÇÁ¼±º´
  • benign familial pemphigus
    ¾ç¼º °¡Á·¼º(åÐàõ Ê«ðéàõ) õÆ÷â(ô¸øÞóê)
  • benign fasciculation
    ¾ç¼º¼¶À¯¼Ó¼º °æÃà (¡­àéë«áÖàõÌâõê).
  • benign juvenile melanoma
    ¾ç¼º ¿¬¼Ò¼º(åÐàõ æÄá´àõ)Èæ»öÁ¾(ýÙßäðþ)
  • benign lichenoid keratosis
    ¾ç¼º ż±¾ç(åÐàõ ÷ÄàÈåÆ)°¢È­Áõ(ÊÇûùñø)
  • benign lymphangioendothelioma
    ¾ç¼º ¸²ÇÁ³»ÇǼ¼Æ÷Á¾
  • benign lymphocytic angiitis
    ¾ç¼º ¸²ÇÁ±¸ Ç÷°ü¿°
  • benign lymphogranulomatosis
    ¾ç¼º¸²ÇÁÀ°¾ÆÁ¾Áõ
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°úÇü¼º(¡­Î¦û¡à÷).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benign
    ¾ç¼º
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)
  • benign tumor
    ¾ç¼ºÁ¾¾ç
  • epilepsy
    °£Áú
  • focal epilepsy
    ÃÊÁ¡¼º °£Áú, ¿îµ¿ ÁßÃß ¼Õ»ó¼º °£Áú, ÀÛ¼Õ°£Áú
  • hysterical epilepsy
    È÷½ºÅ׸®¼º°£Áú
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
  • temporal epilepsy
    ÃøµÎ¼º °£Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TLE Temporal Lobe Epilepsy; ÃøµÎ¿± °£Áú
  = Psychomotor Epilepsy; Á¤½Å ¿îµ¿ °£Áú
  = Tem...
BCE basal cell epithelioma; benign childhood epilepsy; bubble chamber equipment
BFEC benign focal epilepsy of childhood
BOE benign occipital epilepsy
BPEC benign partial epilepsy of childhood; bipolar electrocardiogram
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BFNC Benign Familial Neonatal Convulsions
BCECT Benign Childhood Epilepsy with Centrotemporal Spike
BRE Benign Rolandic Epilepsy
BNBAS Brazelton Neonatal Behavioral Assessment Scale
NAS Neonatal Abstinence Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abortive epilepsy
    ºÎÀü °£Áú
    ´ë¹ßÀÛÀÇ µ·ÁÂÀû, ¶Ç´Â ÈçÀûÀû ¹ßÀÛÀ̶ó°í »ý°¢µÇ´Â °¡º­¿î ¹ßÀÛ. Àü½Å °æ·ÃÀ» µ¿¹ÝÇÏÁö ¾Ê°í Àá½Ã Áö¼ÓÇÏ´Â ½Åü ¶Ç´Â Á¤½Å Áõ»óÀ̸ç, ¶§·Î´Â ÀüÁ¶
  • affect epilepsy
    Á¤µ¿¼º °£Áú
  • akinetic epilepsy
    ¹«µ¿¼º °£Áú
  • epilepsy
    °£Áú
    1. ³ú ±â´ÉÀÇ °©ÀÛ½º·¯¿î ÀϽÃÀû ÀåÇØ. 2. ¹ßÀÛÀ̶õ ½ÅüÀÇ Àüü³ª ÀϺÎ, ÀǽÄÀÇ °©ÀÛ½º·± º¯È­¸¦ ÀÏÀ¸Å°°Å³ª °©ÀÛ½º·¯¿î ´ë³ú ÇÇÁúÀÇ ÀÌ»ó ÈïºÐ »óÅ¿¡ ÀÇÇØ ½Åü·Î ³ªÅ¸³ª´Â ¿©·¯ °¡Áö Áõ¼¼µéÀ» °£Áú¼º ¹ßÀÛÀ̶ó°í ÇÑ´Ù. ÀÌ·¯ÇÑ °£Áú¼º ¹ßÀÛÀÌ Æ¯º°ÇÑ ÀÌÀ¯ ¾øÀÌ ¹Ýº¹µÇ°í, Áö¼ÓµÇ´Â ¸¸¼º ÁúȯÀ» °£ÁúÀ̶ó°í ÇÑ´Ù. ±×·¯¹Ç·Î °£ÁúÀÇ Áõ»óÀº ¿øÀÎÀ̳ª ´ë³úÀÇ º¯È­°¡ ÀϾ´Â ºÎÀ§¿¡ µû¶ó ¸Å¿ì ´Ù¾çÇÏ°Ô ³ªÅ¸³ª°ÔµÇ¸ç ¾ð¶æ º¸À̱⿡ ÀÇ¹Ì ¾øÀÌ º¸ÀÌ´Â °¡º­¿î ½ÅüÀÇ ¹Ýº¹Àû ÇàÀ§, Áï ´«À» ±ôºý°Å¸®°Å³ª, ¼ÕÀ» ¹Ýº¹ÀûÀ¸·Î ÅöÅöÄ¡´Â °Í µî¿¡¼­ºÎÅÍ Àü½Å ¹ßÀÛ, ÀÇ½Ä ¼Ò½Ç¿¡ À̸£±â±îÁö °¢¾ç°¢»öÀÇ Áõ»óÀ» º¸À̸ç, ´ëºÎºÐÀÇ °æ¿ì¿¡ °©Àڱ⠳ªÅ¸³ª±â ¶§¹®¿¡ Áõ»ó ¹ßÇöÀ» ¿¹ÃøÇÒ ¼ö ¾ø´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. °£ÁúÀÇ ¹ß»ý ±âÀüÀº ¿©·¯ °¡Áö ÀÌ·ÐÀÌ ÀÖÀ¸¸ç, ±Ã±ØÀûÀ¸·Î ´ë³ú ÇÇÁúÀÇ ÀÌ»ó°ú ÈïºÐÀ¸·Î ³ªÅ¸³ª¸ç, ³úÀÇ º´º¯À» ÀÏÀ¸Å°´Â ÁúȯÀº ¹ßÀÛÀÇ ¿øÀÎÀÌ µÉ °¡´É¼ºÀÌ ÀÖ´Ù°í º¼ ¼ö ÀÖ´Ù. ±×·¯³ª ½ÇÁ¦ ¿øÀÎÀ» Á¤È®È÷ ¾Ë ¼ö ¾ø´Â Ư¹ß¼º °£ÁúÀÌ 60-70%·Î ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±× ¿Ü ¼±Ãµ¼º Áúȯ, °¨¿°, Á¾¾ç, ³úÁ¹Áß, ÅðÇ༺ Áúȯ, µÎºÎ ¼Õ»ó µî ´Ù¾çÇÏ°Ô ÀÖÀ¸¸ç, ÃÖ±Ù ¼ö¼úÀû Ä¡·á·Î ±× º´¸® ¼Ò°ßÀÌ ¹àÇôÁö°í, ¶ÇÇÑ ÇÙ Àڱ⠰ø¸í ÃÔ¿µ µî ½Å°æ ¿µ»ó Áø´Ü¹ýÀÇ ¹ß´Þ·Î ¿øÀÎÀ» ¾Ë ¼ö ¾ø¾ú´ø ¸¹Àº ¿¹¿¡¼­ »õ·Î¿î ÁúȯÀÌ ±Ô¸íµÇ°í ÀÖ¾î °£Áú Ä¡·á¿¡ Å©°Ô µµ¿òÀÌ µÇ°í ÀÖ´Ù. °£ÁúÀº °£Áú¼º ¹ßÀÛÀÇ Á¾·ù¿¡ µû¶ó ºÐ·ùÇϸç ÃÖ±Ù¿¡´Â º´·Â, ÀÓ»ó Áõ»ó, °¡Á··Â °ü°è, ³úÆÄ ¹× ³ú ¿µ»ó ¼Ò°ß, ¿¹ÈÄ µîÀ» Á¾ÇÕÇÏ¿© °£Áú ¹× °£Áú ÁõÈıºÀ» Ưº°È÷ µû·Î ºÐ·ùÇÏ¿© ¾à¹° Ä¡·á ¹× ¼ö¼úÀû Ä¡·á¿¡ ´ëºñÇϰí ÀÖ´Ù. °£Áú ¹× °£Áú ÁõÈıºÀÇ ºÐ·ù Å©°Ô 2°¡Áö·Î ³ª´­ ¼ö Àִµ¥, ÀÓ»óÀû Áõ»óÀ̳ª ³úÆÄ¼Ò°ßÀÌ ¸ðµÎ ³úÀÇ ±¹¼Ò ºÎÀ§¿¡¼­ ½ÃÀÛÇÏ´Â °ÍÀ» ½Ã»çÇÒ ¶§´Â ºÎºÐ ¹ßÀÛÀ̶ó°í Çϸç, Áõ»ó ÃʱâºÎÅÍ Àü½ÅÀû ¹ßÀÛ Áõ¼¼³ª ÀÇ½Ä ¼Ò½ÇÀÌ ÀÖ´Â °æ¿ì¸¦ Àü½Å ¹ßÀÛÀ̶ó°í ÇÑ´Ù. ºÎºÐ ¹ßÀÛÀº ÀÇ½Ä Àå¾Ö°¡ ÀÖ´Â º¹ÇÕ ºÎºÐ ¹ßÀÛ, ÀÇ½Ä Àå¾Ö°¡ ¾ø´Â °æ¿ì¸¦ ´Ü¼ø ºÎºÐ ¹ßÀÛÀ̶ó°í ÇÑ´Ù. ºÎºÐ ¹ßÀÛ 1
  • focal epilepsy
    ±¹¼Ò °£Áú, ÃÊÁ¡ °£Áú, ¿îµ¿ ÁßÃß ¼Õ»ó¼º °£Áú
  • Jackson's epilepsy
    Àè½¼ °£Áú
    ´ë³úÀÇ ¿îµ¿ ½Å°æ ÁßÃßÀÇ ±¹¼ÒÀû ¼Õ»óÀ¸·Î ÀÎÇØ ±× Áö¹è¸¦ ¹Þ´Â ±ÙÀ°À» Æ÷ÇÔÇÏ´Â ºÎºÐÀû °£Áú.
  • juvenile myoclonic epilepsy
    û¼Ò³â ±Ù °£´ë¼º °£Áú
  • myoclonic epilepsy and raggedred fibers
    °£´ë ±ÙÀ° °æ·Ã¼º °£Áú
  • peripheral epilepsy
    ¸»Ãʼº °£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ °£Áú
    ±ÙÀÇ °£´ë¼º ¿¬ÃàÀº °æµµÀÇ °Í »ÓÀÌÁö¸¸ ÀǽÄÀÇ µ¹¿¬, ¼ø°£ÀûÀÎ »ó½ÇÀÌ ÀϾ´Â °£Áú. ƯÈ÷ ¼Ò¾Æ¿¡°Ô¼­ º¼ ¼ö ÀÖ°í, ¹ßÀÛ Áß°ú °¢ ¹ßÀÛ »çÀÌÀÇ ³úÆÄ¿¡ ³ªÅ¸³ª´Â 3-c.
  • post-traumatic epilepsy
    ¿Ü»óÈÄ °£Áú
  • temporal epilepsy
    ÃøµÎ¼º °£Áú
  • traumatic epilepsy
    ¿Ü»ó¼º °£Áú
  • uncinate epilepsy
    ±¸È¸ °£Áú
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
    µ¿ÀǾî=neonate. Ãâ»ý ÈÄ Ã³À½ 4ÁÖ¸¦ ¾ð±Þ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
benign neonatal convulsions A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance.
(05 Mar 2000)
benign childhood epilepsy with centrotemporal spikes A specific epilepsy syndrome beginning in childhood and remitting in adolescence, characterised by nocturnal simple partial motor seizures or generalised tonic-clonic seizures. EEG shows centrotemporal spikes that are activated by sleep and an otherwise normal EEG background.
(05 Mar 2000)
anaemia, neonatal The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation.
(12 Dec 1998)
Brazelton's Neonatal Behavioural Assessment Scale A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
neonatal diagnosis Systematic evaluation of the newborn for evidence of disease or malformations, and the conclusion reached.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Epilepsy, Benign Neonatal - »õâ A condition marked by recurrent seizures that occur during the first 4-6 weeks of life despite an otherwise benign neonatal course. Autosomal dominant familial and sporadic forms have been identified. Seizures generally consist of brief episodes of tonic posturing and other movements, apnea, eye deviations, and blood pressure fluctuations. These tend to remit after the 6th week of life. The risk of developing epilepsy at an older age is moderately increased in the familial form of this disorder. (Neurologia 1996 Feb;11(2):51-5)
    Synonyms : Benign Familial Neonatal Convulsions, Benign Familial Neonatal Epilepsy, Benign Neonatal Epilepsy, Nonfamilial, Benign Neonatal Non-Familial Convulsions, Benign Neonatal Nonfamilial Epilepsy, Benign Non-Familial Neonatal Convulsions, Benign Neonatal Epilepsy
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epilepsy
    Áö¶öº´;°£Áú
  • neonatal
    ½Å»ý¾ÆÀÇ
  • benign
    Àھַοî; ÀÎÀÚÇÑ; Ä£ÀýÇÑ
  • benign
    ÀÎÁ¤¸¹Àº;Ä£ÀýÇÑ;¿ÂÈ­ÇÑ;¾ç¼­ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á